12 February 2026
12 February 2026
The FDA’s call comes within a wider push from the US government to alter vaccine policy.
Unlike the US, Mexico is bolstering its mRNA offerings with the help of Moderna’s portfolio.
The approvals stem from the Phase III KEYNOTE-B96 trial data, which was presented at the 2025 ESMO Congress.
Uniphar will act as the exclusive distributor for Lymphir in designated European territories.
Analysts said that Yeztugo’s forecast, which would represent 433% year-over-year growth, is achievable.
THX Pharma is set to receive total payments up to $206.1m.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
